UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review

Therapeutic advances in gastroenterology, 2020, Vol.13, p.1756284820952592-1756284820952592

2020

Volltextzugriff (PDF)

Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.367-375

2020

Volltextzugriff (PDF)

The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies

Frontiers in neurology, 2023-03, Vol.14, p.1149604-1149604

2023

Volltextzugriff (PDF)

Infections in inflammatory bowel disease

Deutsche medizinische Wochenschrift (1946), 2016-02, Vol.141 (3), p.196

2016

Volltextzugriff (PDF)

Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in Deutschland: Real-World-Evidenz zu Prävalenz, Erkrankungskombinationen, Versorgung

Zeitschrift für Rheumatologie, 2023-12

2023

Volltextzugriff (PDF)

Su1151 NEXT-GENERATION SEQUENCING FOR INDETERMINATE BILIARY STRICTURES: A RETROSPECTIVE SINGLE-CENTER ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-675-S-675

2024

Volltextzugriff (PDF)

Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz

Zeitschrift für Rheumatologie, 2024-04, Vol.83 (3), p.200-209

2024

Volltextzugriff (PDF)

Sa1765 SYMPTOMATIC REMISSION AND IUS IMPROVEMENTS IN A MULTINATIONAL REAL-WORLD COHORT OF UC PATIENTS TREATED WITH UPADACITINIB - FIRST RESULTS FROM THE IBD-DACH STUDY EUROPE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-513-S-513

2024

Volltextzugriff (PDF)

Mo1843 SUBCUTANEOUS INFLIXIMAB IN CROHN'S DISEASE PATIENTS WITH IMMUNOGENIC FAILURE OF INTRAVENOUS INFLIXIMAB: A RETROSPECTIVE TWO-CENTER STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1139-S-1139

2024

Volltextzugriff (PDF)

SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease—Fear and Desire

Inflammatory bowel diseases, 2021-11, Vol.27 (11), p.1858-1861

2021

Volltextzugriff (PDF)

Anchoring fins of fully covered self-expandable metal stents affect pull-out force and stent migration

Gastrointestinal endoscopy, 2024-03, Vol.99 (3), p.377-386.e3

2024

Volltextzugriff (PDF)

Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel disease

Scientific reports, 2017-10, Vol.7 (1), p.13943-9, Article 13943

2017

Volltextzugriff (PDF)

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis

Crohn's & colitis 360, 2021-04, Vol.3 (2), p.otab011-otab011

2021

Volltextzugriff (PDF)

Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment

The Journal of pathology, 2022-08, Vol.257 (5), p.607-619

2022

Volltextzugriff (PDF)

SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease

Zeitschrift fur Gastroenterologie, 2022-01, Vol.60 (1), p.77

2022

Volltextzugriff (PDF)

Practical Genetic Testing in Gastroenterology

Deutsche medizinische Wochenschrift (1946), 2018-10, Vol.143 (20), p.1477

2018

Volltextzugriff (PDF)

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed By Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 1 - Efficacy Analysis

Oral surgery, oral medicine, oral pathology and oral radiology, 2023-02, Vol.135 (2), p.e42-e43

2023

Volltextzugriff (PDF)

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed by Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 2 – Pain, Subjective Measures and Safety Analysis

Oral surgery, oral medicine, oral pathology and oral radiology, 2023-02, Vol.135 (2), p.e43-e44

2023

Volltextzugriff (PDF)

Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care

Zeitschrift für Rheumatologie, 2023-12

2023

Volltextzugriff (PDF)

Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy

Zeitschrift für Rheumatologie, 2024-04, Vol.83 (3), p.200-209

2024

Volltextzugriff (PDF)

Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz

Zeitschrift für Rheumatologie, 2023-01, Vol.83 (3), p.200-209

2023

Volltextzugriff (PDF)

Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease

Zeitschrift fur Gastroenterologie, 2021-11, Vol.59 (11), p.1189

2021

Volltextzugriff (PDF)

Tu1227 Treatment of Refractory Crohn's Disease With Allogeneic, Bone Marrow-Derived Adult Mesenchymal Stromal Cells

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-779-S-779

2012

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Budesonide for Prophylaxis of Acute Intestinal Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation (PROGAST)

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-31-S-31

2011

Volltextzugriff (PDF)

T1171 Miniprobe Confocal Laser Microscopy Imaging in Gastrointestinal Graft-Versus-Host Disease

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-515-A-515

2009

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionInternational Bibliography of Art (IBA)

SpracheJapanisch

ThemaEradication

ThemaGraft Vs Host Disease - Etiology

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)
Berichte
(1)

Sprache

Englisch
(24)
Deutsch
(9)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review

Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome

The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies

Infections in inflammatory bowel disease

Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in Deutschland: Real-World-Evidenz zu Prävalenz, Erkrankungskombinationen, Versorgung

Su1151 NEXT-GENERATION SEQUENCING FOR INDETERMINATE BILIARY STRICTURES: A RETROSPECTIVE SINGLE-CENTER ANALYSIS

Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz

Sa1765 SYMPTOMATIC REMISSION AND IUS IMPROVEMENTS IN A MULTINATIONAL REAL-WORLD COHORT OF UC PATIENTS TREATED WITH UPADACITINIB - FIRST RESULTS FROM THE IBD-DACH STUDY EUROPE

Mo1843 SUBCUTANEOUS INFLIXIMAB IN CROHN'S DISEASE PATIENTS WITH IMMUNOGENIC FAILURE OF INTRAVENOUS INFLIXIMAB: A RETROSPECTIVE TWO-CENTER STUDY

SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease—Fear and Desire

Anchoring fins of fully covered self-expandable metal stents affect pull-out force and stent migration

Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel disease

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis

Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment

SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease

Practical Genetic Testing in Gastroenterology

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed By Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 1 - Efficacy Analysis

Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed by Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 2 – Pain, Subjective Measures and Safety Analysis

Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care

Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy

Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz

Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease

Tu1227 Treatment of Refractory Crohn's Disease With Allogeneic, Bone Marrow-Derived Adult Mesenchymal Stromal Cells

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Budesonide for Prophylaxis of Acute Intestinal Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation (PROGAST)

T1171 Miniprobe Confocal Laser Microscopy Imaging in Gastrointestinal Graft-Versus-Host Disease

Aktive Filter

Suchergebnisse filtern